D
Dominique Stoppa-Lyonnet
Researcher at Curie Institute
Publications - 444
Citations - 32995
Dominique Stoppa-Lyonnet is an academic researcher from Curie Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 80, co-authored 420 publications receiving 29316 citations. Previous affiliations of Dominique Stoppa-Lyonnet include PSL Research University & Bosch.
Papers
More filters
Journal ArticleDOI
First description of a sporadic breast cancer in a woman with BRCA1 germline mutation
Elsa Curtit,Vanessa Benhamo,Nadège Gruel,Nadège Gruel,Tatiana Popova,Elodie Manie,Paul Cottu,Odette Mariani,Dominique Stoppa-Lyonnet,Xavier Pivot,Xavier Pivot,Marc-Henri Stern,A Vincent-Salomon,A Vincent-Salomon +13 more
TL;DR: The case of a woman carrying a germline pathogenic BRCA1 mutation diagnosed with a breast cancer overexpressing HER2 represents the first biological demonstration for the existence of a sporadic HER2-positive breast cancer independent from BRC a loss of function in a woman carrier of a deleterious BRCa1 mutation.
Journal ArticleDOI
Les facteurs de risque génétiques et environnementaux des cancers de l’endomètre
Claire Senechal,Edouard Cottereau,Antoine De Pauw,Camille Elan,Isabelle Dagousset,Virginie Fourchotte,Marion Gauthier-Villars,Marick Laé,Dominique Stoppa-Lyonnet,Dominique Stoppa-Lyonnet,Bruno Buecher +10 more
TL;DR: L’objectif de cette synthese est de decrire les principaux facteurs de risque de cancer de l’endometre en soulignant les acquisitions recentes and de faire le point sur les modalites de surveillance and prise en charge des femmes a risque eleve.
Journal ArticleDOI
Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Anne Brédart,Jean-Luc Kop,Julia Dick,Alejandra Cano,Antoine De Pauw,Amélie Anota,Joan Brunet,Peter Devilee,Dominique Stoppa-Lyonnet,Rita K. Schmutzler,Sylvie Dolbeault,Sylvie Dolbeault +11 more
TL;DR: In women tested for breast or ovarian cancer genetic risk in European genetics clinics, psychosocial problems were mostly unaffected by genetic testing.
Book ChapterDOI
Communication in genetic counselling for breast/ovarian cancer.
TL;DR: While unidirectional transfer of information from the geneticist to the counselee has been the preferred method in cancer genetics for a long time, a model based on patient-centered communication is more adequate in predictive medicine and allows shared decision making.
Journal ArticleDOI
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Elena Vigorito,Karoline Kuchenbaecker,Jonathan Beesley,Julian Adlard,Bjarni A. Agnarsson,Irene L. Andrulis,Banu Arun,Laure Barjhoux,Muriel Belotti,Javier Benitez,Andreas Berger,Anders Bojesen,Bernardo Bonanni,Carole Brewer,Trinidad Caldés,Maria A. Caligo,Ian G. Campbell,Salina B. Chan,Kathleen Claes,David E. Cohn,Jackie Cook,Mary B. Daly,Francesca Damiola,Rosemarie Davidson,Antoine De Pauw,Capucine Delnatte,Orland Diez,Susan M. Domchek,Martine Dumont,Katarzyna Durda,Bernd Dworniczak,Douglas F. Easton,Diana Eccles,Christina Edwinsdotter Ardnor,Ros Eeles,Bent Ejlertsen,Steve Ellis,D. Gareth Evans,Lídia Feliubadaló,Florentia Fostira,William D. Foulkes,Eitan Friedman,Debra Frost,Pragna Gaddam,Patricia A. Ganz,Judy Garber,Vanesa García-Barberán,Marion Gauthier-Villars,Andrea Gehrig,Anne-Marie Gerdes,Sophie Giraud,Andrew K. Godwin,David E. Goldgar,Christopher R. Hake,Thomas Hansen,Sue Healey,Shirley Hodgson,Frans B. L. Hogervorst,Claude Houdayer,Peter J. Hulick,Evgeny N. Imyanitov,Claudine Isaacs,Louise Izatt,Angel Izquierdo,Lauren Jacobs,Anna Jakubowska,Ramunas Janavicius,Katarzyna Jaworska-Bieniek,Uffe Birk Jensen,Esther M. John,Joseph Vijai,Beth Y. Karlan,Karin Kast,KCon Fab Investigators,Sofia Khan,Ava Kwong,Yael Laitman,Jenny Lester,Fabienne Lesueur,Annelie Liljegren,Jan Lubinski,Phuong L. Mai,Siranoush Manoukian,Sylvie Mazoyer,Alfons Meindl,Arjen R. Mensenkamp,Marco Montagna,Katherine L. Nathanson,Susan L. Neuhausen,Heli Nevanlinna,Dieter Niederacher,Edith Olah,Olufunmilayo I. Olopade,Kai Ren Ong,Ana Osorio,Sue K. Park,Ylva Paulsson-Karlsson,Inge Søkilde Pedersen,Bernard Peissel,Paolo Peterlongo,Georg Pfeiler,Catherine M. Phelan,Marion Piedmonte,Bruce Poppe,Miquel Angel Pujana,Paolo Radice,Gad Rennert,Gustavo C. Rodriguez,Matti A. Rookus,Eric A. Ross,Rita K. Schmutzler,Jacques Simard,Christian F. Singer,Thomas P. Slavin,Penny Soucy,Melissa C. Southey,Doris Steinemann,Dominique Stoppa-Lyonnet,Grzegorz Sukiennicki,Christian Sutter,Csilla Szabo,Muy Kheng Tea,Manuel R. Teixeira,Soo-Hwang Teo,Mary Beth Terry,Mads Thomassen,Maria Grazia Tibiletti,Laima Tihomirova,Silvia Tognazzo,Elizabeth J. van Rensburg,Liliana Varesco,Raymonda Varon-Mateeva,Athanassios Vratimos,Jeffrey N. Weitzel,Lesley McGuffog,Judy Kirk,Amanda E. Toland,Ute Hamann,Noralane M. Lindor,Susan J. Ramus,Mark H. Greene,Fergus J. Couch,Kenneth Offit,Paul D.P. Pharoah,Georgia Chenevix-Trench,Antonis C. Antoniou +145 more
TL;DR: The ovarian cancer association at 9p22.2 may be mediated by different variants in BRCA1 mutation carriers and in the general population, and potentially different mechanisms may underlie ovarian cancer risk for mutation carrier and the generalpopulation.